We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$3.06B
AUM Growth
-$59.7M
Cap. Flow
-$149M
Cap. Flow %
-4.86%
Top 10 Hldgs %
25.7%
Holding
170
New
5
Increased
22
Reduced
51
Closed
8

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$1.24M
2
BMY icon
Bristol-Myers Squibb
BMY
+$895K
3
EW icon
Edwards Lifesciences
EW
+$791K
4
VFC icon
VF Corp
VFC
+$432K
5
NVO
Novo Nordisk
NVO
+$238K

Sector Composition

Rank Sector Weight
1 Technology 24.45%
2 Healthcare 21.61%
3 Industrials 20.47%
4 Consumer Staples 15.98%
5 Consumer Discretionary 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITUB icon
151
Itaú Unibanco
ITUB
$91.3B
$219K 0.01%
45,353
RDS.A
152
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$201K 0.01%
4,015
CDE icon
153
Coeur Mining
CDE
$15.6B
$166K 0.01%
14,000
ORAN
154
DELISTED
Orange
ORAN
$166K 0.01%
10,672
OVV icon
155
Ovintiv
OVV
$17.5B
$138K ﹤0.01%
2,640
LTM
156
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$109K ﹤0.01%
13,384
ABEV icon
157
Ambev
ABEV
$47.3B
$91K ﹤0.01%
15,000
ENIA
158
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$82K ﹤0.01%
10,000
ULBI icon
159
Ultralife
ULBI
$88.3M
$41K ﹤0.01%
10,000
ENIC icon
160
Enel Chile
ENIC
$5.96B
-10,000
Closed -$58K
FSLR icon
161
First Solar
FSLR
$21.8B
-4,200
Closed -$204K
GILD icon
162
Gilead Sciences
GILD
$161B
-4,282
Closed -$357K
GNTX icon
163
Gentex
GNTX
$4.88B
-309,700
Closed -$4.79M
TEF
164
DELISTED
Telefonica
TEF
-173,060
Closed -$1.27M
NJ
165
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
-53,406
Closed -$1M
MDVN
166
DELISTED
MEDIVATION, INC.
MDVN
-5,606
Closed -$338K

Similar funds

Saturna Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Saturna Capital held 170 positions worth $3.06B, down 1.9% from $3.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Saturna Capital withdrew a net $149M in Q3 2016, closing 8 positions and reducing 51 holdings. Its most notable exit was Gentex, an estimated $4.79M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Saturna Capital opened a new position in Edwards Lifesciences worth $844K.

  • Saturna Capital's largest Q3 2016 buy was Edwards Lifesciences: 21,000 shares worth $844K.
  • Saturna Capital added most to Abbott in Q3 2016, an estimated $1.24M increase.
  • Saturna Capital's biggest Q3 2016 reduction was Akamai, cutting an estimated $29.5M.
  • Saturna Capital fully exited Gentex in Q3 2016, selling an estimated $4.79M.
  • Saturna Capital's ten largest holdings make up 26% of its $3.06B portfolio in Q3 2016.
  • Saturna Capital opened 5 new positions and closed 8 in Q3 2016.
  • Saturna Capital's portfolio value fell 1.9% quarter-over-quarter to $3.06B.

Based on Saturna Capital's 13F filing for Q3 2016, filed 14 Nov 2016.